Phenylbutyrate therapy for maple syrup urine disease-Reference-Cited by-同舟云学术

Phenylbutyrate therapy for maple syrup urine disease

Published:2010-11-23 Issue:4 Volume:20 Page:631-640
ISSN:1460-2083
Container-title:Human Molecular Genetics
language:en
Short-container-title:

Author:

Brunetti-Pierri Nicola,Lanpher Brendan,Erez Ayelet,Ananieva Elitsa A.,Islam Mohammad,Marini Juan C.,Sun Qin,Yu Chunli,Hegde Madhuri,Li Jun,Wynn R. Max,Chuang David T.,Hutson Susan,Lee Brendan

Publisher

Oxford University Press (OUP)

Subject

Genetics(clinical),Genetics,Molecular Biology,General Medicine

Link

http://academic.oup.com/hmg/article-pdf/20/4/631/17253672/ddq507.pdf

Reference49 articles.

1. Diagnosis and treatment of maple syrup disease: a study of 36 patients;Morton;Pediatrics,2002

2. Maple syrup urine disease: clinical, EEG, and plasma amino acid correlations with a theoretical mechanism of acute neurotoxicity;Korein;Int. J. Neurosci.,1994

3. A new variant of maple syrup urine disease (branched chain ketoaciduria). Clinical and biochemical evaluation;Schulman;Am. J. Med.,1970

4. Intermittent branched-chain ketonuria. Variant of maple-syrup-urine disease;Dancis;N. Engl. J. Med.,1967

5. Social outcome in adults with maple syrup urine disease (MSUD);Simon;J. Inherit. Metab. Dis.,2007

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Computational structural genomics and clinical evidence suggest BCKDK gain‐of‐function may cause a potentially asymptomatic maple syrup urine disease phenotype;JIMD Reports;2024-04-08

2. Pubertal origin of growth retardation in inborn errors of protein metabolism: A longitudinal cohort study;Molecular Genetics and Metabolism;2024-03

3. Branched-chain keto acids promote an immune-suppressive and neurodegenerative microenvironment in leptomeningeal disease;2023-12-18

4. Identification of putative allosteric inhibitors of BCKDK via virtual screening and biological evaluation;Journal of Enzyme Inhibition and Medicinal Chemistry;2023-12-07

5. Inborn Errors of Metabolism with Ataxia: Current and Future Treatment Options;Cells;2023-09-19